v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2013
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Anti-dilutive securities excluded from the computation of basic and diluted net loss per share are as follows:
 
 
 
December 31,
 
 
 
2013
 
2012
 
Warrants to purchase common stock
 
10,429,900
 
2,629,000
 
Options to purchase common stock
 
812,500
 
2,000,000
 
Shares issuable upon conversion of convertible notes and accrued interest
 
953,560
 
-
 
Series A Convertible Preferred Stock
 
2,457,269
 
2,200,000
 
Series B Convertible Preferred Stock
 
623,779
 
309,900
 
 
 
 
 
 
 
Totals
 
15,277,008
 
7,139,800
 
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Financial liabilities as of December 31, 2013 and 2012 measured at fair value on a recurring basis are summarized below:
 
 
 
 
 
 
Quoted Prices
 
Significant
 
 
 
 
 
 
 
 
 
in Active
 
Other
 
Significant
 
 
 
 
 
 
Markets for
 
Observable
 
Unobservable
 
 
 
December 31,
 
Identical Assets
 
Inputs
 
Inputs
 
 
 
2013
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Derivative liabilities
 
$
1,248,943
 
$
 
$
 
$
1,248,943
 
 
 
 
 
 
 
Quoted Prices
 
Significant
 
 
 
 
 
 
 
 
 
in Active
 
Other
 
Significant
 
 
 
 
 
 
Markets for
 
Observable
 
Unobservable
 
 
 
December 31,
 
Identical Assets
 
Inputs
 
Inputs
 
 
 
2012
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
Derivative liabilities
 
$
730,174
 
$
 
$
 
$
730,174
 
Schedule of Derivative Instruments [Table Text Block]
The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis for the years ended December 31, 2013 and 2012:
 
 
2013
 
2012
 
Balance - Beginning of period
 
$
730,174
 
$
580,000
 
Derivative instruments issued
 
 
438,375
 
 
83,673
 
Change in fair value of derivative liabilities
 
 
80,394
 
 
66,501
 
 
 
 
 
 
 
 
 
Balance - End of period
 
$
1,248,943
 
$
730,174